Clinical Trials Logo

Pathological Gambling clinical trials

View clinical trials related to Pathological Gambling.

Filter by:

NCT ID: NCT01381250 Completed - Clinical trials for Pathological Gambling

Effects of Internet-based Treatment of Pathological Gambling

Start date: May 2004
Phase: N/A
Study type: Interventional

A trial testing the outcome of an Internet-based treatment of pathological gambling with the hypothesis that there will be improvements both immediately and up to 36 months. It is also hypnotized that treatment response can be predicted from background variables.

NCT ID: NCT01340274 Withdrawn - Clinical trials for Pathological Gambling

Community Reinforcement Approach and Family Training (CRAFT) for Problem Gambling

Start date: June 3, 2011
Phase: Phase 2
Study type: Interventional

Nova Scotia is experiencing a proliferation of gambling opportunities and their related gambling problems. The 2003 Nova Scotia Prevalence Study (2004) found that approximately 50,000 adult Nova Scotians are at some risk for problem gambling and that approximately 93,000 adult Nova Scotians are intimately connected to at least one person who has a gambling problem. The serious consequences of problem gambling are being felt by the Individuals engaging in Problem Gambling (IPGs), their Concerned Significant Others (CSOs) and their Communities. Very few IPGs access support services for their gambling problems. Some reports (National Gambling Impact Study Commission 1999) have found that only 3% of IPGs seek treatment. The Nova Scotia Gambling Prevalence Study (2004) states: "Overall, 3.5% (26,000 adults) have been motivated to help someone else with a current gambling problem versus 0.5% (3,700 adults) seeking assistance or information for a personal problem". While the CSOs of IPGs are seven times more likely to access professional addiction treatment the options for these individuals are limited and treatment programs often lack evidence in support of their effectiveness. The Community Reinforcement and Family Training (CRAFT) (Meyers & Wolfe 2004) approach provides significant benefits to the CSOs of persons abusing alcohol and other drugs. They benefits include: improvement in the quality of life of the CSOs; increasing the rate of substance abusers entering treatment; and decreased substance use. CRAFT empowers CSOs by providing tools to positively influence theirs and their significant other's behavior. The current study investigates the applicability and effectiveness of the CRAFT approach to the CSOs of IPGS. It is predicted that benefits to the CSOs receiving CRAFT will significantly surpass those receiving treatment as usual. The predicted benefits are: improvement in quality of life for the CSO; engagement of IPGs in treatment; and decreased gambling by the IPGs. With these achieved outcomes, this research will provide opportunity for earlier intervention, improved individual and family functioning and a reduction of the negative impact of problem gambling on the community.

NCT ID: NCT01215357 Completed - Clinical trials for Pathological Gambling

Clinical Study to Determine if Ecopipam Can Reduce Urges to Gamble

Start date: October 2010
Phase: Phase 2
Study type: Interventional

This study is designed to test the hypothesis that ecopipam is able to reduce urges to gamble in patients diagnosed with Pathological Gambling.

NCT ID: NCT01154712 Recruiting - Clinical trials for Pathological Gambling

Deep Low-Frequency Repetitive Transcranial Magnetic Stimulation for Cessation of Pathological Gambling

Start date: June 2010
Phase: Phase 1
Study type: Interventional

Pathological gambling (PG) is characterized by a persistent pattern of continued gambling behavior despite its adverse consequences. PG is a chronic, progressive, male-dominated disorder, which has a prevalence of 1% to 3.4% among US adults. Deep transcranial magnetic stimulation (TMS) is a novel neuro-stimulation method capable of inhibiting neuronal activity when given in low frequency. The hypothesis of this study is that , Pathological gambling will be ameliorated if low frequency magnetic field using Brainsway H1 coil will be applied to the left dorso-lateral prefrontal cortex of these patients.

NCT ID: NCT01135264 Active, not recruiting - Clinical trials for Pathological Gambling

Cognitive-Motivational Behavior Therapy for Pathological Gamblers

Start date: August 2009
Phase: N/A
Study type: Interventional

In the proposed two-arm randomized controlled trial, 200 patients meeting DSM-IV criteria for PG will be randomized to 12 sessions of Cognitive-Motivational Behavior Therapy (CMBT) or to Cognitive Behavior Therapy (CBT).

NCT ID: NCT01057862 Completed - Clinical trials for Pathological Gambling

Investigation of Naltrexone for Pathological Gambling

Start date: February 2009
Phase: Phase 2
Study type: Interventional

The investigators plan to investigate the safety, tolerability, and efficacy of the opioid antagonist naltrexone in Pathological Gambling. We hypothesize that naltrexone will be superior to placebo in reducing gambling urges and behavior, when combined with adjuvant non-pharmacological treatment as usual.

NCT ID: NCT00927563 Completed - Clinical trials for Pathological Gambling

Tolcapone Treatment of Pathological Gambling

Start date: June 2009
Phase: Phase 2
Study type: Interventional

The goal of the proposed study is to evaluate the efficacy and safety of tolcapone in pathological gambling.

NCT ID: NCT00685724 Completed - Clinical trials for Pathological Gambling

A Pilot SMART Design for Pathological Gamblers

SMART
Start date: January 2008
Phase: N/A
Study type: Interventional

Pathological gambling is serious problem, with significant psychological, financial, and public health consequences. Nevertheless, controlled trials examining the efficacy of therapeutic interventions for pathological gamblers are sparse, and many pathological gamblers recover on their own, or with only minimal interventions. In this initial study of a SMART design for pathological gamblers, we will offer a brief intervention to all (n = 100), and subsequently randomize individuals based upon their initial treatment response to varying intensities of additional care from none to 8 sessions of individual cognitive behavioral therapy (CBT) plus 14 weeks of Aftercare. Gambling outcomes will be assessed pre-treatment and at about weeks 10, 24, 36 and 52.

NCT ID: NCT00585169 Completed - Clinical trials for Pathological Gambling

Memantine Treatment Study of Pathological Gambling

Start date: December 2007
Phase: Phase 2
Study type: Interventional

The goal of the proposed study is to evaluate the efficacy and safety of the drug memantine in individuals with pathological gambling (PG). Thirty subjects with DSM-IV PG will receive 10 weeks of open-label treatment with memantine. The hypothesis to be tested is that memantine will be effective and well tolerated in patients with PG. We hypothesize that memantine will reduce the severity of gambling symptoms and improve patients' overall functioning. This study will provide needed data on the treatment of a disabling disorder that currently lacks a clearly effective treatment.

NCT ID: NCT00580567 Completed - Clinical trials for Pathological Gambling

Impulsivity in Pathological Gambling

Start date: March 2007
Phase: N/A
Study type: Observational

The purpose of the this study is to compare pathological gamblers versus non-pathological gamblers using tests that measure different components of impulsivity. We aim to invite a total of 120 individuals to participate in this study. Impulsivity has been described as the cognitive inability to delay gratification, a failure to inhibit behavioral action or acting without forethought about consequences. Impulsivity has also been seen as a personality trait characterized by risk-taking or sensation seeking behavior. Pathological gamblers demonstrate aspects of impulsivity; they act without thinking, have difficult inhibiting urges to gamble and desire immediate gratification. The goal of this project is to clarify which components of impulsivity are associated with pathological gambling. Non-treatment seeking, pathological gamblers and controls will be recruited from the community and local casinos. Each participant will be administered a battery of tests that represent different operational definitions of impulsivity.